Attached files
| file | filename |
|---|---|
| 8-K - BioElectronics Corp | v207798_8-k.htm |
| EX-99.2 - BioElectronics Corp | v207798_ex99-2.htm |
Exhibit
99.1
BioElectronics
Corporation Engages MUNCmedia to Lead 12 Month Real-Time Retail Investor
Communications Program
FREDERICK,
MD--(Marketwire - December 22, 2010) - BioElectronics Corporation (PINKSHEETS:
BIEL) is
pleased to announce the engagement of MUNCmedia to conduct communications with
retail investors via their real-time information media network. MUNCmedia
utilizes an innovative, transparent communications strategy specifically focused
on individual investors with a long-term investment focus. BioElectronics has
entered into a 12 month contract with MUNCmedia which will facilitate direct
communications into MUNCmedia's network of over 90 million retail investors and
two live presentations at RetailInvestorConferences.com.
Retail
investors, often overlooked and underappreciated, are continuing to show their
strength and ability in the purchase of early-stage companies' stock on an
individual basis. A 2010 report issued by ING DIRECT USA/ShareBuilder
paints a very optimistic portrait of today's retail investors and the escalating
trend of self-reliant individual investors in the purchase of stocks on the
public markets. MUNCmedia's network reaches and communicates with these
individual investors.
"MUNCmedia
is focused on helping companies like BioElectronics to achieve a balance in
their shareholder base between, for example, Private Equity funds as long-term
shareholders and a strong retail investor following with long-term investment
goals. BioElectronics is optimistic about the opportunities to utilize
MUNCmedia's Investor Relations programs which target Main Street retail
investors," said Andrew Whelan, CEO of BioElectronics.
"We laud
BioElectronics for already thinking and working like a large-cap company in
regard to transparency," said Matt Bird, CEO of MUNCmedia. "Their commitment to
openness and equal treatment toward all investors will certainly bring
commercial and financial rewards. We look forward to helping BioElectronics tell
their story to a worldwide audience."
About
BioElectronics:
BioElectronics Corporation
(PINKSHEETS: BIEL) is the maker of safe, inexpensive,
drug-free medical devices and patches that deliver pulsed electromagnetic energy
to relieve pain and inflammation. The company's wafer thin patches contain an
embedded microchip and battery that deliver pulsed electromagnetic energy, a
clinically proven and widely accepted anti-inflammatory and pain relief therapy
that heretofore has only been possible to obtain from large, facility-based
equipment. BioElectronics markets and sells its current products under the brand
names ActiPatch®, RecoveryRx™, Allay™ Menstrual Pain Therapy and HealFast™
Therapy for cats, dogs and horses. The company is headquartered in Frederick,
MD. For more information, visit www.bielcorp.com.
About MUNCmedia: Market Update Network,
Corp.
MUNCmedia
is the first Information Media Network and world leader in web-based Retail
Investor Targeting solutions. We provide online corporate communications,
research and media solution to companies worldwide.
From
targeting press releases one-to-one to individual investors to Retail Investor
Conferences, MUNCmedia helps companies deliver targeted and scalable messages to
the precise audience in real-time. Hundreds of companies, IR and PR agencies,
stock exchanges and integrated newswires rely on MUNCmedia services to deliver
news messages to the retail financial community every day with measurable
results.
MUNCmedia
was founded in 2006 and is headquartered in New York, NY with regional offices
in Bellevue, WA, Vancouver, BC and Boston. We currently service over 500 direct
public company issuers, 40 IR agency partners and have sales and marketing
partners across the globe.
Forward-Looking
Statements:
This press release may include
"forward-looking statements" within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934,
as amended. Although the Company believes that the expectations reflected in
such forward-looking statements are reasonable, it can give no assurance that
such expectations reflected in such forward-looking statements will prove to
have been correct. BioElectronic's actual results could differ materially from
those anticipated in the forward-looking statements. BioElectronics refers you
to the cautionary statements and risk factors set forth in the documents it
files with the Securities and Exchange Commission (http://www.sec.gov). The Company is under no obligation
(and expressly disclaims any obligation) to update or alter its forward-looking
statements, whether as a result of new information, future events, or
otherwise